Continuous Glucose Monitoring Systems: Applications and Integrated Benefits - review study
DOI:
https://doi.org/10.12775/QS.2025.48.66899Keywords
continuous glucose monitoring, diabetes mellitus, hypoglycemia, gestational diabetes, physical activity, critical careAbstract
Introduction: Continuous Glucose Monitoring (CGM) systems have evolved significantly, transforming the management of diabetes and expanding into various other fields. Originally developed to aid in diabetes management, CGM systems now offer real-time glucose tracking, providing insights into glycemic control, preventing hypoglycemia, and optimizing therapeutic decisions. These systems are used in type 1 and type 2 diabetes management, pregnancy, sports, and critical care. Despite their benefits, challenges such as cost and integration into routine care remain. Future research will be crucial to fully understand the long-term impact and cost-effectiveness of CGM systems.
Aim of the study: This study aims to present the diverse applications and integrated benefits of Continuous Glucose Monitoring (CGM) systems. It focuses on their role in improving diabetes management, enhancing pregnancy outcomes, supporting athletic performance, and optimizing care in critical conditions.
Materials and methods: A literature review was conducted using PubMed as the primary database. The search terms included: "continuous glucose monitoring", “CGM”, “diabetes mellitus", “diabetes mellitus type 1”, “diabetes mellitus type 2”.
Conclusion: Continuous glucose monitoring (CGM) systems have significantly advanced diabetes care, offering precise, real-time glycemic data that support individualized treatment. This review highlights CGM’s broadening applications across diverse populations, including non-diabetic individuals, pregnant women, athletes, and critically ill patients. While strong evidence supports CGM’s clinical and behavioral benefits, further research is required to optimize cost-effectiveness, long-term outcomes, and broader implementation strategies. CGM represents a transformative tool in both chronic disease management and personalized health monitoring.
References
[1] El Malahi A, Van Elsen M, Charleer S, et al. Relationship Between Time in Range, Glycemic Variability, HbA1c, and Complications in Adults With Type 1 Diabetes Mellitus. J Clin Endocrinol Metab. 2022;107(2):e570-e581. doi:10.1210/clinem/dgab688
[2] Campbell JE, Newgard CB. Mechanisms controlling pancreatic islet cell function in insulin secretion. Nat Rev Mol Cell Biol. 2021;22(2):142-158. doi:10.1038/s41580-020-00317-7
[3] American Diabetes Association Professional Practice Committee . 7. Diabetes Technology: Standards of Care in Diabetes-2025 [published correction appears in Diabetes Care. 2025 Apr 1;48(4):666. doi: 10.2337/dc25-er04b.]. Diabetes Care. 2025;48(Supplement_1):S146-S166. doi:10.2337/dc25-S007
[4] Merino J, Linenberg I, Bermingham KM, et al. Validity of continuous glucose monitoring for categorizing glycemic responses to diet: implications for use in personalized nutrition. Am J Clin Nutr. 2022;115(6):1569-1576. doi:10.1093/ajcn/nqac026
[5] Raza, S., Raza, S., Kazmi, M., Saad, M. and Hussain, I. (2021) 100 Years of Glucose Monitoring in Diabetes Management. Journal of Diabetes Mellitus, 11, 221-233. doi: 10.4236/jdm.2021.115019
[6] Clarke SF, Foster JR. A history of blood glucose meters and their role in self-monitoring of diabetes mellitus. Br J Biomed Sci. 2012;69(2):83-93.
[7] Didyuk O, Econom N, Guardia A, Livingston K, Klueh U. Continuous Glucose Monitoring Devices: Past, Present, and Future Focus on the History and Evolution of Technological Innovation. J Diabetes Sci Technol. 2021;15(3):676-683. doi:10.1177/1932296819899394
[8] Rodríguez García J, Camiña Darriba F, Ortolá Devesa JB, Rodríguez-Segade Villamarín S, Valle Rodríguez A. Parameters of glycemic variability in continuous glucose monitoring as predictors of diabetes: a prospective evaluation in a non-diabetic general population. Adv Lab Med. 2025;6(1):46-51. Published 2025 Mar 7. doi:10.1515/almed-2025-0011
[9] Horgan R, Hage Diab Y, Fishel Bartal M, Sibai BM, Saade G. Continuous Glucose Monitoring in Pregnancy. Obstet Gynecol. 2024;143(2):195-203. doi:10.1097/AOG.0000000000005374
[10] Flockhart M, Larsen FJ. Continuous Glucose Monitoring in Endurance Athletes: Interpretation and Relevance of Measurements for Improving Performance and Health. Sports Med. 2024;54(2):247-255. doi:10.1007/s40279-023-01910-4
[11] Sadhu AR, Serrano IA, Xu J, et al. Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study. J Diabetes Sci Technol. 2020;14(6):1065-1073. doi:10.1177/1932296820964264
[12] Cappon G, Vettoretti M, Sparacino G, Facchinetti A. Continuous Glucose Monitoring Sensors for Diabetes Management: A Review of Technologies and Applications. Diabetes Metab J. 2019;43(4):383-397. doi:10.4093/dmj.2019.0121
[13] Dovc K, Battelino T. Evolution of Diabetes Technology. Endocrinol Metab Clin North Am. 2020;49(1):1-18. doi:10.1016/j.ecl.2019.10.009
[14] Chen C, Zhao XL, Li ZH, Zhu ZG, Qian SH, Flewitt AJ. Current and Emerging Technology for Continuous Glucose Monitoring. Sensors (Basel). 2017;17(1):182. Published 2017 Jan 19. doi:10.3390/s17010182
[15] Dunn TC, Ajjan RA, Bergenstal RM, Xu Y. Is It Time to Move Beyond TIR to TITR? Real-World Data from Over 20,000 Users of Continuous Glucose Monitoring in Patients with Type 1 and Type 2 Diabetes. Diabetes Technol Ther. 2024;26(3):203-210. doi:10.1089/dia.2023.0565
[16] Hanson K, Kipnes M, Tran H. Comparison of Point Accuracy Between Two Widely Used Continuous Glucose Monitoring Systems. J Diabetes Sci Technol. 2024;18(3):598-607. doi:10.1177/19322968231225676
[17] Sacks DB, Arnold M, Bakris GL, et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Diabetes Care. 2023;46(10):e151-e199. doi:10.2337/dci23-0036
[18] World Health Organization. Diabetes. Accessed April 13, 2025. https://www.who.int/health-topics/diabetes#tab=tab_1
[19] Seidu S, Kunutsor SK, Ajjan RA, Choudhary P. Efficacy and Safety of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring in Patients With Type 2 Diabetes: A Systematic Review and Meta-analysis of Interventional Evidence. Diabetes Care. 2024;47(1):169-179. doi:10.2337/dc23-1520
[20] Schnell O, Alawi H, Battelino T, et al. Self-monitoring of blood glucose in type 2 diabetes: recent studies. J Diabetes Sci Technol. 2013;7(2):478-488. Published 2013 Mar 1. doi:10.1177/193229681300700225
[21] van Beers CA, DeVries JH, Kleijer SJ, et al. Continuous glucose monitoring for patients with type 1 diabetes and impaired awareness of hypoglycaemia (IN CONTROL): a randomised, open-label, crossover trial. Lancet Diabetes Endocrinol. 2016;4(11):893-902. doi:10.1016/S2213-8587(16)30193-0
[22] Marks BE, Wolfsdorf JI. Monitoring of Pediatric Type 1 Diabetes. Front Endocrinol (Lausanne). 2020;11:128. Published 2020 Mar 17. doi:10.3389/fendo.2020.00128
[23] Zhou Y, Sardana D, Kuroko S, et al. Comparing the glycaemic outcomes between real-time continuous glucose monitoring (rt-CGM) and intermittently scanned continuous glucose monitoring (isCGM) among adults and children with type 1 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2024;41(3):e15280. doi:10.1111/dme.15280
[24] Chase HP, Beck RW, Xing D, et al. Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation continuous glucose monitoring randomized trial. Diabetes Technol Ther. 2010;12(7):507-515. doi:10.1089/dia.2010.0021
[25] Hilliard ME, Levy W, Anderson BJ, et al. Benefits and Barriers of Continuous Glucose Monitoring in Young Children with Type 1 Diabetes. Diabetes Technol Ther. 2019;21(9):493-498. doi:10.1089/dia.2019.0142
[26] Foster NC, Miller KM, Tamborlane WV, Bergenstal RM, Beck RW; T1D Exchange Clinic Network. Continuous Glucose Monitoring in Patients With Type 1 Diabetes Using Insulin Injections. Diabetes Care. 2016;39(6):e81-e82. doi:10.2337/dc16-0207
[27] Liu TYA, Shpigel J, Khan F, et al. Use of Diabetes Technologies and Retinopathy in Adults With Type 1 Diabetes. JAMA Netw Open. 2024;7(3):e240728. Published 2024 Mar 4. doi:10.1001/jamanetworkopen.2024.0728
[28] Jiao Y, Lin R, Hua X, et al. A systematic review: Cost-effectiveness of continuous glucose monitoring compared to self-monitoring of blood glucose in type 1 diabetes. Endocrinol Diabetes Metab. 2022;5(6):e369. doi:10.1002/edm2.369
[29] Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group [published correction appears in Lancet 1999 Aug 14;354(9178):602]. Lancet. 1998;352(9131):837-853.
[30] Ajjan RA, Battelino T, Cos X, et al. Continuous glucose monitoring for the routine care of type 2 diabetes mellitus. Nat Rev Endocrinol. 2024;20(7):426-440. doi:10.1038/s41574-024-00973-1
[31] Martens T, Beck RW, Bailey R, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin: A Randomized Clinical Trial. JAMA. 2021;325(22):2262-2272. doi:10.1001/jama.2021.7444
[32] Beck RW, Riddlesworth TD, Ruedy K, et al. Continuous Glucose Monitoring Versus Usual Care in Patients With Type 2 Diabetes Receiving Multiple Daily Insulin Injections: A Randomized Trial. Ann Intern Med. 2017;167(6):365-374. doi:10.7326/M16-2855
[33] Vigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2012). Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes care, 35(1), 32–38. https://doi.org/10.2337/dc11-1438
[34] Lind N, Christensen MB, Hansen DL, Nørgaard K. Comparing continuous glucose monitoring and blood glucose monitoring in adults with inadequately controlled, insulin-treated type 2 diabetes (Steno2tech study): a 12-month, single-center, randomized controlled trial. Diabetes Care. 2024;47(5):881-889. doi:10.2337/dc23-2194
[35] Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. Diabetes Ther. 2017;8(1):55-73. doi:10.1007/s13300-016-0223-6
[36] Yoo HJ, An HG, Park SY, et al. Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract. 2008;82(1):73-79. doi:10.1016/j.diabres.2008.06.015
[37] Manfredo J, Lin T, Gupta R, et al. Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications. Front Endocrinol (Lausanne). 2023;14:1182260. Published 2023 May 29. doi:10.3389/fendo.2023.1182260
[38] Feig DS, Hwee J, Shah BR, Booth GL, Bierman AS, Lipscombe LL. Trends in incidence of diabetes in pregnancy and serious perinatal outcomes: a large, population-based study in Ontario, Canada, 1996–2010. Diabetes Care. 2014;37(6):1590-1596. doi:10.2337/dc13-2717
[39] Levy CJ, Foster NC, DuBose SN, et al. Changes in Device Uptake and Glycemic Control Among Pregnant Women With Type 1 Diabetes: Data From the T1D Exchange. J Diabetes Sci Technol. 2021;15(6):1297-1302. doi:10.1177/1932296820972123
[40] Feig DS, Donovan LE, Corcoy R, et al. Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial [published correction appears in Lancet. 2017 Nov 25;390(10110):2346. doi: 10.1016/S0140-6736(17)32712-5.]. Lancet. 2017;390(10110):2347-2359. doi:10.1016/S0140-6736(17)32400-5
[41] Persson M, Pasupathy D, Hanson U, Norman M. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study. Diabetes Care. 2011;34(5):1145-1149. doi:10.2337/dc10-2406
[42] Murphy HR, Howgate C, O'Keefe J, et al. Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study. Lancet Diabetes Endocrinol. 2021;9(3):153-164. doi:10.1016/S2213-8587(20)30406-X
[43] Rizos EC, Markozannes G, Charitakis N, et al. Continuous Glucose Monitoring in Type 1 Diabetes, Type 2 Diabetes, and Diabetes During Pregnancy: A Systematic Review With Meta-Analysis of Randomized Controlled Trials. Diabetes Technol Ther. Published online 2025. doi:10.1089/dia.2024.0599
[44] Law GR, Alnaji A, Alrefaii L, et al. Suboptimal Nocturnal Glucose Control Is Associated With Large for Gestational Age in Treated Gestational Diabetes Mellitus. Diabetes Care. 2019;42(5):810-815. doi:10.2337/dc18-2212
[45] Kluemper JR, Smith A, Wobeter B. Diabetes: the role of continuous glucose monitoring. Drugs Context. 2022;11:2021-9-13. Published 2022 Jun 14. doi:10.7573/dic.2021-9-13
[46] Li Z, Beck R, Durnwald C, et al. Continuous Glucose Monitoring Prediction of Gestational Diabetes Mellitus and Perinatal Complications. Diabetes Technol Ther. 2024;26(11):787-796. doi:10.1089/dia.2024.0080
[47] Clausen TD, Mathiesen ER, Hansen T, et al. High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia. Diabetes Care. 2008;31(2):340-346. doi:10.2337/dc07-1596
[48] Paing AC, McMillan KA, Kirk AF, Collier A, Hewitt A, Chastin SFM. Impact of free-living pattern of sedentary behaviour on intra-day glucose regulation in type 2 diabetes. Eur J Appl Physiol. 2020;120(1):171-179. doi:10.1007/s00421-019-04261-z
[49] Cockcroft EJ, Narendran P, Andrews RC. Exercise-induced hypoglycaemia in type 1 diabetes. Exp Physiol. 2020;105(4):590-599. doi:10.1113/EP088219
[50] Abdulrahman A, Manhas J, Linane H, Gurney M, Fitzgerald C, O'Sullivan E. Use of continuous glucose monitoring for sport in type 1 diabetes. BMJ Open Sport Exerc Med. 2018;4(1):e000432. Published 2018 Dec 17. doi:10.1136/bmjsem-2018-000432
[51] Rilstone S, Oliver N, Godsland I, Tanushi B, Thomas M, Hill N. A Randomized Controlled Trial Assessing the Impact of Continuous Glucose Monitoring with a Predictive Hypoglycemia Alert Function on Hypoglycemia in Physical Activity for People with Type 1 Diabetes (PACE). Diabetes Technol Ther. 2024;26(2):95-102. doi:10.1089/dia.2023.0376
[52] Houlder SK, Yardley JE. Continuous Glucose Monitoring and Exercise in Type 1 Diabetes: Past, Present and Future. Biosensors (Basel). 2018;8(3):73. Published 2018 Aug 3. doi:10.3390/bios8030073
[53] Riddell MC, Milliken J. Preventing exercise-induced hypoglycemia in type 1 diabetes using real-time continuous glucose monitoring and a new carbohydrate intake algorithm: an observational field study. Diabetes Technol Ther. 2011;13(8):819-825. doi:10.1089/dia.2011.0052
[54] Laffel LM, Kanapka LG, Beck RW, et al. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial. JAMA. 2020;323(23):2388-2396. doi:10.1001/jama.2020.6940
[55] Kulawiec DG, Zhou T, Knopp JL, Chase JG. Continuous glucose monitoring to measure metabolic impact and recovery in sub-elite endurance athletes. Biomed Signal Process Control. 2021;70:103059. doi:10.1016/j.bspc.2021.103059
[56] Ishihara K, Uchiyama N, Kizaki S, Mori E, Nonaka T, Oneda H. Application of Continuous Glucose Monitoring for Assessment of Individual Carbohydrate Requirement during Ultramarathon Race. Nutrients. 2020;12(4):1121. Published 2020 Apr 17. doi:10.3390/nu12041121
[57] Agarwal S, Mathew J, Davis GM, et al. Continuous Glucose Monitoring in the Intensive Care Unit During the COVID-19 Pandemic. Diabetes Care. 2021;44(3):847-849. doi:10.2337/dc20-2219
[58] Faulds ER, Boutsicaris A, Sumner L, et al. Use of Continuous Glucose Monitor in Critically Ill COVID-19 Patients Requiring Insulin Infusion: An Observational Study. J Clin Endocrinol Metab. 2021;106(10):e4007-e4016. doi:10.1210/clinem/dgab409
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Klaudia Goleniewska, Jakub Miasnikiewicz, Kamil Ciechomski, Wiktoria Cecuła, Joanna Rypel-Bośka, Natalia Siuta, Aleksandra Stupecka, Marcin Migiel, Izabela Brynczka
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Stats
Number of views and downloads: 57
Number of citations: 0
